Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV.
A case report of drug-induced rhabdomyolysis in a 34-year-old HIV-infected male with a history of liver disease and concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir is presented.
Mah Ming
Jinell B
JB
Southern Alberta HIV Clinic, Calgary Health Region, Calgary, Alberta, Canada.
Gill
M John
MJ
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000069059:Atorvastatin; D017291:Clarithromycin / Q000009:adverse effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006538:Heptanoic Acids / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D061466:Lopinavir; D008297:Male; D011744:Pyrimidinones / Q000009:adverse effects*; D011758:Pyrroles / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced*; D019438:Ritonavir / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D017320:HIV Protease Inhibitors; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011744:Pyrimidinones; D011758:Pyrroles; D061466:Lopinavir; D000069059:Atorvastatin; D017291:Clarithromycin; D019438:Ritonavir